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CASE STUDY
Cryptococcal meningitis associated 
with increased adenosine deaminase in the 
cerebrospinal fluid
Yuji Tanaka* and Kazuo Satomi
Abstract 
Introduction:  Clinically, increased cerebrospinal fluid (CSF) adenosine deaminase (ADA) level is an important 
diagnostic clue of tuberculous meningitis. However, increased CSF ADA level can be caused by other neurological 
diseases.
Case description: We report a case of a 67-year-old woman with cryptococcal meningitis presented with increased 
ADA level of the CSF. In parallel with her recovery, the ADA level of CSF decreased steadily. This is the first case 
described the chronological change in CSF ADA level of the patient with cryptococcal meningitis in detail.
Discussion and Evaluation: Clinically, increased CSF ADA level is an important diagnostic clue of tuberculous 
meningitis. However, previously, it was reported that increased CSF ADA level can be caused by other neurological 
diseases. In this case, the patient was diagnosed with cryptococcal meningitis, and the possibility of coinfection with 
tuberculous meningitis has been discarded by the negative PCR, negative cultures and the clinical course. In addition, 
the chronological change in CSF ADA level was useful for follow-up assessment.
Conclusions: Cryptococcal meningitis should be considered for the differential diagnosis for diseases presented 
increased CSF ADA.
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Introduction
Clinically, increased cerebrospinal fluid (CSF) adenosine 
deaminase (ADA) level is an important diagnostic clue of 
tuberculous meningitis (TBM). However, increased CSF 
ADA level can be caused by other neurological diseases. 
We report of an older patient with cryptococcal menin-
gitis associated with increased CSF ADA level, in which 
information on the chronological change in ADA level 
was useful for follow-up assessment.
Case description
A 67-year-old woman was diagnosed with hypertension at 
age 30 years. Her family had no history of active tubercu-
losis, but the patient had bred a hill myna. Three months 
before admission to the hospital, the patient initially 
developed a slight fever and headache. After 3  months, 
the patient could not walk independently and her level of 
consciousness declined, for which the patient was admit-
ted to our hospital. A neurological examination revealed 
reduced consciousness (Glasgow coma scale; E3 V3 M5) 
and meningeal irritation, hyperreflexia of all four-extrem-
ities, and positive Babinski response. Blood examination 
revealed normal findings, including inflammatory reac-
tions, and negative results for human immunodeficiency 
virus antibody. In the CSF examination, the cell count was 
46/µL (all lymphocytes); the protein level, 142 mg/dL (ref-
erence range 10–40 mg/dL); glucose level, 31 mg/dL (ref-
erence range 50–75 mg/dL); and ADA level, increased to 
12.7  U/L (reference range <9.0  U/L) (Ribera et  al. 1987). 
The India ink smear yielded a positive result, and Crypto-
coccus antigen was detected. A mycological culture of CSF 
revealed Cryptococcus neoformans. The mycobacterium 
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cultures and polymerase chain reactions (PCR) of CSF, 
sputum, urine, and gastric juice repeatedly yielded nega-
tive results. Brain magnetic resonance imaging revealed 
hydrocephalus and an abnormal enhancement effect at the 
brain base (Fig. 1). Chest computed tomography revealed 
normal findings. According to these findings, cryptococ-
cal meningitis was diagnosed. Administration of ampho-
tericin B and flucytosine were initiated. At 1 month after 
admission, the CSF ADA level decreased to 5.6  U/L. At 
4  months after admission, antimycotic therapy improved 
the patient’s symptoms and the Cryptococcal antigen in 
CSF disappeared. In parallel with her recovery, the CSF 
ADA level decreased steadily (Fig. 2).
Discussion
We describe an older woman with increased CSF ADA 
level, who was diagnosed with cryptococcal meningitis 
rather than TBM. In addition, the chronological change 
in CSF ADA level was useful for follow-up assessment.
Clinically, increased CSF ADA level is an important diag-
nostic clue of TBM. Definite diagnosis of TBM requires 
detection of tubercle bacilli in CSF, and the most com-
monly used tests are CSF smears and/or cultures. Smear 
microscopy is quick and inexpensive but has low sensitiv-
ity (0–20%) (Tuon et al. 2010). Culture methods require up 
to 8  weeks and have variable sensitivity (10–90%) (Tuon 
et al. 2010). Moreover, CSF ADA level is a more sensitive 
indicator than PCR for the diagnosis of TBM (Rana et al. 
2010). Additionally, CSF ADA level can be evaluated in 
resource-poor settings, including small general hospitals 
and non-specialized hospitals for infectious diseases, and 
contribute to a quick and accurate diagnosis.
ADA is an enzyme that catalyzes the deamination of 
adenosine, forming inosine in the process (Erel et  al. 
1998). The chief physiological function of ADA is related 
to lymphocytic proliferation and differentiation (Erel 
et  al. 1998). Activity is found to be elevated in diseases 
with cell-mediated immune response and is a marker of 
cellular immunity (Erel et  al. 1998). The mechanism of 
increased CSF ADA level has not been fully elucidated. 
One of the widely accepted theories is that increased ADA 
level is due to intrathecal synthesis after activation of 
monocyte–macrophages (Schutte et al. 2001). One reason 
is because ADA plays an important role in monocyte-to-
macrophage maturation, and another is because the ADA 
(2), which is one of the two ADA isoenzymes, is the major 
Fig. 1 Brain magnetic resonance imaging on admission. The scan revealed hydrocephalus and an abnormal enhancement effect at the brain base
Page 3 of 4Tanaka and Satomi  SpringerPlus  (2016) 5:2093 
contributor to increased CSF ADA level, probably reflect-
ing the monocyte–macrophage origin of ADA (Schutte 
et al. 2001). These speculations suggest that increased CSF 
ADA level can be caused by TBM and other neurological 
diseases. However, in this case, the possibility of coinfec-
tion with TBM has been discarded by the negative PCR, 
negative cultures and the clinical course.
Previously, it was reported that increased CSF ADA 
level can be caused by other diseases such as sarcoid 
meningitis, meningeal involvement with leukemia or 
lymphoma, cerebral toxoplasmosis, cerebral infarction, 
neurosyphilis, listeria meningitis, and other aseptic men-
ingitis (Nishida et al. 2007). In general, these are diseases 
that activate the lymphocytes to on turn activate the 
monocyte–macrophage system in a similar way to how 
granulomas are made. These include infectious and non-
infectious causes. Thus, the differential diagnosis should 
include other neurological diseases.
Only two cases of cryptococcal meningitis associated with 
increased CSF ADA level have been described in the lit-
erature (Izumoto et al. 1991; Martínez et al. 1992). Because 
there was not the chronological change of CSF ADA level 
in previous reports, it was not clear whether increased CSF 
ADA level was caused by cryptococcal meningitis. In this 
case, the CSF ADA level at admission increased and in par-
allel with her recovery, the CSF ADA level decreased stead-
ily. This is the first case described the chronological change 
in CSF ADA level of the patient with cryptococcal menin-
gitis in detail. From the detailed observation of CSF ADA 
level, the determination of CSF ADA level was useful for 
follow-up assessment of cryptococcal meningitis.
Conclusions
In conclusion, we report an older patient with cryptococ-
cal meningitis associated with increased CSF ADA level, 
in which information on the chronological change in CSF 
ADA level was useful for follow-up assessment. Although 
the determination of CSF ADA level can be useful for 
early differential diagnosis of TBM, other neurologi-
cal diseases such as cryptococcal meningitis should be 
considered.
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Fig. 2 Clinical course. ADA adenosine deaminase, CSF cerebrospinal fluid
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